Intellia (NTLA) director receives 9,200 RSUs and 13,300 options

Rhea-AI Filing Summary

Intellia Therapeutics director Frank Verwiel received new equity awards. He was granted 9,200 restricted stock units, each representing a contingent right to receive one share of Intellia common stock. Following this grant, he holds 35,148 common shares directly.

He was also awarded a stock option for 13,300 shares of common stock at an exercise price of $12.89 per share. This option vests in full on the earlier of the first anniversary of the June 9, 2026 grant date or the next annual meeting of stockholders, and expires on June 8, 2036.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Verwiel Frank

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	13,300	$0.00	--
Grant/Award	Common Stock	9,200	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 13,300 shares (Direct, null); Common Stock — 35,148 shares (Direct, null)

Footnotes (1)

1. Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

Key Figures

RSU grant: 9,200 units Common shares held: 35,148 shares Option grant size: 13,300 shares +3 more

6 metrics

RSU grant 9,200 units Restricted stock units granted to director

Common shares held 35,148 shares Direct common stock ownership after grants

Option grant size 13,300 shares Underlying common stock for new option

Option exercise price $12.89 per share Strike price for newly granted option

Option expiration June 8, 2036 Expiration date of stock option grant

Grant date June 9, 2026 Date RSUs and option were granted

Key Terms

restricted stock units, Stock Option (right to buy), exercise price, vests in full, +1 more

5 terms

restricted stock units financial

"Based on a grant of restricted stock units representing a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (right to buy) financial

"Stock Option (right to buy) with respect to 13,300 shares"

exercise price financial

"conversion or exercise price of 12.8900 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests in full financial

"option was granted ... and vests in full on the earlier to occur"

annual meeting of stockholders financial

"earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/10/2026 - 07:08 PM Accepted by SEC EDGAR 06/10/2026 - 07:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verwiel Frank

(Last) (First) (Middle)

C/O INTELLIA THERAPEUTICS, INC.

40 ERIE STREET; SUITE 130

(Street)

CAMBRIDGE MASSACHUSETTS 02139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Intellia Therapeutics, Inc. [ NTLA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/09/2026		A		9,200	A	$0.00	35,148	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$12.89	06/09/2026		A		13,300		(2)	06/08/2036	Common Stock	13,300	$0.00	13,300	D

Explanation of Responses:

1. Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

2. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

	James Basta, attorney-in-fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Intellia Therapeutics (NTLA) report for Frank Verwiel?

Intellia reported that director Frank Verwiel received equity awards, not open-market trades. He was granted 9,200 restricted stock units and a stock option covering 13,300 shares, both as compensation grants rather than purchases or sales in the market.

How many Intellia (NTLA) shares does Frank Verwiel hold after this Form 4 filing?

After the reported grants, Frank Verwiel holds 35,148 shares of Intellia common stock directly. In addition, he holds a newly granted stock option covering 13,300 underlying common shares, which provides potential future ownership if exercised after vesting.

What are the details of the stock option granted to Frank Verwiel at Intellia (NTLA)?

The stock option covers 13,300 shares of Intellia common stock at an exercise price of $12.89 per share. It was granted on June 9, 2026, and vests in full on the earlier of the first anniversary of grant or the next annual stockholder meeting.

What does the 9,200 restricted stock unit grant at Intellia (NTLA) represent?

The 9,200 restricted stock units represent a contingent right to receive one share of Intellia common stock for each unit. These units are part of director compensation and convert into actual shares only when the specified vesting conditions are satisfied in the future.

When does Frank Verwiel’s new Intellia (NTLA) stock option expire?

The newly granted Intellia stock option to Frank Verwiel expires on June 8, 2036. This long-dated option provides the right, after vesting, to buy up to 13,300 shares at a fixed $12.89 exercise price before that expiration date.